Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    Cystic Fibrosis Patients Are Living Longer Thanks to Improved Clinical Practices and Therapies
    source: pixabay.com

    Cystic Fibrosis Patients Are Living Longer Thanks to Improved Clinical Practices and Therapies

      My American Nurse recently carried an uplifting article showing increasingly positive changes for cystic fibrosis (CF) patients. A network of over one hundred thirty centers throughout the U.S. provide…

    Continue Reading Cystic Fibrosis Patients Are Living Longer Thanks to Improved Clinical Practices and Therapies
    A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement
    source: pixabay.com

    A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement

      A recent article in ANCA Vasculitis News highlighted a Chinese study of ANCA-associated vasculitis (AAV), a group of autoimmune diseases. An earlier Chinese study suggested that the risk of…

    Continue Reading A Chinese Study Finds Higher Risk of Relapse and Resistance to Therapy in AAV Patients With Lung Involvement
    Antiphospholipid Syndrome (APS): Young Women are Five Times More Likely Than Men to Have This Rare Disease
    source: pixabay.com

    Antiphospholipid Syndrome (APS): Young Women are Five Times More Likely Than Men to Have This Rare Disease

    According to a recent article in Healio, the National Institute of Health states that one-third of strokes occurring for the first time to people under fifty can be linked to…

    Continue Reading Antiphospholipid Syndrome (APS): Young Women are Five Times More Likely Than Men to Have This Rare Disease
    Clinical Trial of MGTA-456 Looks Promising for Inherited Metabolic Disorders
    source: pixabay.com

    Clinical Trial of MGTA-456 Looks Promising for Inherited Metabolic Disorders

      According to an article in BioPortfolio, Magenta Therapeutics, a biotechnology company based in Cambridge, Mass., recently announced updates to its Phase II trial of MGTA-456 for the treatment of…

    Continue Reading Clinical Trial of MGTA-456 Looks Promising for Inherited Metabolic Disorders
    ICYMI: She was Diagnosed with Hashimoto’s Thyroiditis but her Doctor Didn’t Know How to Treat It
    source: pixabay.com

    ICYMI: She was Diagnosed with Hashimoto’s Thyroiditis but her Doctor Didn’t Know How to Treat It

      Susan Mann was seven years old when she was diagnosed as having Hashimoto’s thyroiditis, an autoimmune disease that affects the thyroid. According to a recent article in the online…

    Continue Reading ICYMI: She was Diagnosed with Hashimoto’s Thyroiditis but her Doctor Didn’t Know How to Treat It
    Mitochondrial Disease Patient’s Parents Lose Law Suit Against Four Doctors and Boston Children’s Hospital
    source: pixabay.com

    Mitochondrial Disease Patient’s Parents Lose Law Suit Against Four Doctors and Boston Children’s Hospital

      The Boston Globe recently interviewed the principals in a case brought by the Pelletier family against the Boston Children’s Hospital. The article gives details about a family’s charge of…

    Continue Reading Mitochondrial Disease Patient’s Parents Lose Law Suit Against Four Doctors and Boston Children’s Hospital
    Neurodegenerative-Neuromuscular Diseases and Airway Clearance Therapy
    source: pixabay.com

    Neurodegenerative-Neuromuscular Diseases and Airway Clearance Therapy

      Advances in medicine have been responsible for longer overall survival in patients with neurodegenerative-neuromuscular diseases. According to a recent report in RTMagazine, an increase in the number of patients…

    Continue Reading Neurodegenerative-Neuromuscular Diseases and Airway Clearance Therapy
    This College Student Turned her Spastic Diplegic Cerebral Palsy into Projects for the Disabled
    source: pixabay.com

    This College Student Turned her Spastic Diplegic Cerebral Palsy into Projects for the Disabled

      Jennifer Schlegel’s life began earlier than expected with an unanticipated disease. According to an article in The Lantern, Jennifer was born prematurely and diagnosed with spastic diplegic cerebral palsy.…

    Continue Reading This College Student Turned her Spastic Diplegic Cerebral Palsy into Projects for the Disabled

    The EMA Grants PRIME Designation to Viralym-M To Treat Viral Infections Linked to Stem Cell Transplant

      According to a recent article in The Pharma Letter, the European Medicines Agency (EMA) granted PRIME (PRIority MEdicines) designation to Viralym-M based on positive results from a Phase 2 proof-of-concept…

    Continue Reading The EMA Grants PRIME Designation to Viralym-M To Treat Viral Infections Linked to Stem Cell Transplant
    Toxic Protein Identified: Closing in on Alzheimer’s and Neurodegenerative Diseases
    source: pixabay.com

    Toxic Protein Identified: Closing in on Alzheimer’s and Neurodegenerative Diseases

      For years scientists have tried to understand how and why tau, well known to researchers for its implication in Alzheimer’s disease, changes from its normal form to a harmful…

    Continue Reading Toxic Protein Identified: Closing in on Alzheimer’s and Neurodegenerative Diseases
    Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“
    source: pixabay.com

    Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“

      The ASCO Post recently reported findings of high response rates and improved survival from the combination of platinum-based cisplatin and gemcitabine (chemotherapy) in BRCA/PALB2 mutation positive pancreatic ductal adenocarcinoma. The goal…

    Continue Reading Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“
    The FDA is Developing, Approving, and Expediting Exciting New Therapies
    source: pixabay.com

    The FDA is Developing, Approving, and Expediting Exciting New Therapies

      Janet Woodcock, Director of the FDA’s Center for Drug Evaluation and Research (CDER) recently gave an interview to the publication FDA Voices about the agency’s approval in 2019 of a…

    Continue Reading The FDA is Developing, Approving, and Expediting Exciting New Therapies